Business – November 30, 2020
TrueNewsBlog (TNB) Staff
Biotech company Moderna will apply Monday for an emergency use authorization from the U.S. Food and Drug Administration after receiving more good news about the safety and effectiveness of its candidate COVID-19 vaccine. It will be the second vaccine maker to request authorization from the federal government, following similarly positive results for Pfizer and its German collaborator BioNTech’s candidate vaccine.
Moderna’s latest findings, according to a company press release, showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo, while only 11 received the active vaccine. That works out to an effectiveness rate above 94%.
Of the 30 participants who suffered severe disease, all were in the placebo group, suggesting that the vaccine prevents both mild and serious disease. One placebo recipient died.
Return the home page TRUENEWSBLOG to read more.